Outset Medical Inc (OM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Outset Medical Inc (OM) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.63 Million) by net assets ($96.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Outset Medical Inc for the company's overall valuation and market capitalisation.
Outset Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Outset Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Outset Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Outset Medical Inc ranked by their cash flow conversion efficiency. See Outset Medical Inc debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inversa Prime SOCIMI S.A.
MC:YIPS
|
-0.029x |
|
Newfield Resources Ltd
AU:NWF
|
0.201x |
|
Samwon Steel
KO:023000
|
0.020x |
|
Introl S.A.
WAR:INL
|
0.034x |
|
Neontech Co. Ltd
KQ:306620
|
0.108x |
|
EQL PHARMA AB
F:7JK
|
0.063x |
|
Lida Holdings Ltd
TW:4552
|
0.005x |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
-0.917x |
Annual Cash Flow Conversion Efficiency for Outset Medical Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. View OM live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $126.95 Million | $-46.33 Million | -0.365x | +91.59% |
| 2024-12-31 | $26.82 Million | $-116.30 Million | -4.337x | -305.64% |
| 2023-12-31 | $122.89 Million | $-131.37 Million | -1.069x | -80.46% |
| 2022-12-31 | $245.99 Million | $-145.73 Million | -0.592x | -70.13% |
| 2021-12-31 | $374.08 Million | $-130.26 Million | -0.348x | -15.57% |
| 2020-12-31 | $328.61 Million | $-99.02 Million | -0.301x | -259.54% |
| 2019-12-31 | $-372.19 Million | $-70.29 Million | 0.189x | +17.10% |
| 2018-12-31 | $-287.95 Million | $-46.44 Million | 0.161x | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more